Technology could reduce the environmental impact of 3-D printed buildings by adapting locally harvested soils

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology's make-or-break moment.

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health

Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives

With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive

Kelvin Droegemeier takes over the agency until Congress confirms nominee

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Thought leaders in life sciences weigh in on lessons learned amid the COVID-19 pandemic

Scientists look to convalescent plasma, hyperimmune therapy, and monoclonal antibodies to treat COVID-19

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Mauro Ferrari quits after three months at the helm

Structural data on the complex could guide drug and vaccine design

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Work continues on chemical risks, climate, and what data regulators may consider

A new generation of technologies being used for the diagnosis, treatment, and prevention of COVID-19 will be pressure tested amid a pandemic

US EPA considers evaluating risks of D4 under the Toxic Substances Control Act

Industries press pause on steep growth trajectory

Gilead's Chief Medical Officer talks about the challenges of clinical design in the time of COVID-19

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds

These biomolecules could hold clues to why the virus is so infectious and how to stop it

Japanese government plans to buy at least 2 million tablets of the influenza drug

Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2

As wipes and sprays sell out, quaternary ammonium compound makers try to keep up

Early earnings figures from chemical makers are down

Tests of 10 or more novel vaccines could be underway by mid-May

Japanese government plans to buy at least 2 million courses of the influenza drug

Viral levels higher than expected based on confirmed COVID-19 cases

COVID-19 is driving a fivefold or greater increase in demand

National labs, universities, and companies around the world are fast-tracking proposals to use their high-performance computer resources against the novel coronavirus

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system

Watercolor pigment's structure is unlike that of other natural blues from anthocyanins and indigo

Members of the Division of Colloid and Surface Chemistry presented 155 virtual talks over 3 days

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds

US EPA considers evaluating risks of D4 under the Toxic Substances Control Act

Stephanie Wright of King's College London discusses what's known about microplastics and how much more there is to learn

Manufacturing experts weigh in on Gilead's challenge in making its potential COVID-19 treatment